Additional file 10: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Additional file 1: of Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate

Tjalf Ziemssen (352981)
Yossi Gilgun-Sherki (3553031)

October 2015

Patient perception of glatiramer acetate treatment efficacy by geographic region. aP < .0001 for Lat...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Additional file 9: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S5. Prevalence of use of incretin-based medicines per geographic area. (ZIP 7 kb

Additional file 8: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S4. Incidence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 7: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S3. Prevalence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 6: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S2. Age-sex standardized incidence of use of incretin-based medicines among antidiabetic drug...

Additional file 5: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S1. Age-sex standardized prevalence of use of incretin-based medicines among antidiabetic dru...

Additional file 11: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Table S2a and S2b. Percentage of new users of GLP1 analogues by first active substance received. (DO...

Additional file 1: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 1. Antidiabetic drugs of interest for the study, as available in Italy during the observati...

Additional file 2: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 2. Exposure categories for the description of antidiabetic drug treatment received by new i...

Additional file 4: of Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims

Maria Wertli (3210867)
Oliver Reich (618300)
Andri Signorell (696242)
Jakob Burgstaller (3799819)
Johann Steurer (5157)
Ulrike Held (20101)

February 2017

Geographical variation in increase of the use of strong opioids between 2006 and 2013 and variation ...

Additional file 1: of Prevalence of antibiotic use in a tertiary care hospital in Italy, 2008â2016

Marta Ciofi degli Atti (357036)
Carmen DâAmore (6715688)
Jacopo Ceradini (6715676)
Valerio Paolini (6715679)
Gaetano Ciliento (6715682)
Giuseppe Chessa (6715685)
Massimiliano Raponi (3559715)

May 2019

Trend analysis of the proportion of patients treated with antibiotics by indication and type of mole...

Additional file 1: of Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark

Pia Kristensen (6627023)
SĂ¸ren Johnsen (6627026)
Reimar Thomsen (3446630)

April 2019

Table S2. shows volume of antibiotics DDD per 1000 person-years from 2006 to 2015 according to sex a...

Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment?

Ferrajolo, Carmen
Arcoraci, Vincenzo
Sullo, Maria Giuseppa
Rafaniello, Concetta
Sportiello, Liberata
Ferrara, Rosarita
Cannata, Angelo
Pagliaro, Claudia
Tari, Michele Giuseppe
Caputi, Achille
Rossi, Francesco
Trifirò, Gianluca
Capuano, Annalisa

July 2014

textabstractObjectives: We sought to evaluate the prescribing pattern of statins according to nation...

Additional file 1: of Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate

Tjalf Ziemssen (352981)
Yossi Gilgun-Sherki (3553031)

October 2015

Patient perception of glatiramer acetate treatment efficacy by geographic region. aP < .0001 for Lat...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Additional file 9: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S5. Prevalence of use of incretin-based medicines per geographic area. (ZIP 7 kb

Additional file 8: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S4. Incidence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 7: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S3. Prevalence of use of incretin-based medicines by age and gender. (ZIP 58 kb

Additional file 6: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S2. Age-sex standardized incidence of use of incretin-based medicines among antidiabetic drug...

Additional file 5: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Figure S1. Age-sex standardized prevalence of use of incretin-based medicines among antidiabetic dru...

Additional file 11: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Table S2a and S2b. Percentage of new users of GLP1 analogues by first active substance received. (DO...

Additional file 1: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 1. Antidiabetic drugs of interest for the study, as available in Italy during the observati...

Additional file 2: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Giuseppe Roberto (3139791)
Francesco Barone-Adesi (355270)
Francesco Giorgianni (523751)
Valeria Pizzimenti (6314552)
Carmen Ferrajolo (605704)
Michele Tari (5893799)
Claudia Bartolini (6314555)
Roberto Da Cas (433997)
Marina Maggini (275336)
Stefania Spila-Alegiani (357034)
Paolo Francesconi (535541)
Gianluca TrifirĂ˛ (6314561)
Elisabetta Poluzzi (487411)
Fabio Baccetti (6314558)
Rosa Gini (451348)

February 2019

Appendix 2. Exposure categories for the description of antidiabetic drug treatment received by new i...

Additional file 4: of Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims

Maria Wertli (3210867)
Oliver Reich (618300)
Andri Signorell (696242)
Jakob Burgstaller (3799819)
Johann Steurer (5157)
Ulrike Held (20101)

February 2017

Geographical variation in increase of the use of strong opioids between 2006 and 2013 and variation ...

Additional file 1: of Prevalence of antibiotic use in a tertiary care hospital in Italy, 2008â2016

Marta Ciofi degli Atti (357036)
Carmen DâAmore (6715688)
Jacopo Ceradini (6715676)
Valerio Paolini (6715679)
Gaetano Ciliento (6715682)
Giuseppe Chessa (6715685)
Massimiliano Raponi (3559715)

May 2019

Trend analysis of the proportion of patients treated with antibiotics by indication and type of mole...

Additional file 1: of Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark

Pia Kristensen (6627023)
SĂ¸ren Johnsen (6627026)
Reimar Thomsen (3446630)

April 2019

Table S2. shows volume of antibiotics DDD per 1000 person-years from 2006 to 2015 according to sex a...

Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment?

Ferrajolo, Carmen
Arcoraci, Vincenzo
Sullo, Maria Giuseppa
Rafaniello, Concetta
Sportiello, Liberata
Ferrara, Rosarita
Cannata, Angelo
Pagliaro, Claudia
Tari, Michele Giuseppe
Caputi, Achille
Rossi, Francesco
Trifirò, Gianluca
Capuano, Annalisa

July 2014

textabstractObjectives: We sought to evaluate the prescribing pattern of statins according to nation...

Additional file 1: of Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate

Tjalf Ziemssen (352981)
Yossi Gilgun-Sherki (3553031)

October 2015

Patient perception of glatiramer acetate treatment efficacy by geographic region. aP < .0001 for Lat...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Roberto G.
Barone-Adesi F.
Giorgianni F.
Pizzimenti V.
Ferrajolo C.
Tari M.
Bartolini C.
Da Cas R.
Maggini M.
Spila-Alegiani S.
Francesconi P.
Trifiro G.
Poluzzi E.
Baccetti F.
Gini R.

January 2019

Background: The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitor...

Additional file 10: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Abstract

Extracted data

Additional file 10: of Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

Abstract

Extracted data

Related items

Related items